Dissociation of the inhibitory effects of 2-deoxy-D-glucose on Vero cell growth and the replication of herpes simplex virus
- PMID: 6100424
- PMCID: PMC183726
- DOI: 10.1128/AAC.22.2.284
Dissociation of the inhibitory effects of 2-deoxy-D-glucose on Vero cell growth and the replication of herpes simplex virus
Abstract
Vero cells treated for 24 h with a concentration of 2-deoxy-D-glucose (2dGlc) that inhibited the production of infectious herpes simplex virus type 1 grew at the same rate as untreated cells. Longer exposures to 2dGlc inhibited the growth of Vero cells in a dose-dependent manner, but without any loss of viability, and could be reversed by replating the cells in the absence of drug. To exhibit antiviral activity, 2dGlc had to be present during the replication cycle of herpes simplex virus type 1. Treatment of Vero cells, even with a cytotoxic dose of 2dGlc, was without effect on the yield of infectious virus, provided the drug was removed before infection. Thus the antiviral effects of 2dGlc were not the result of, and appeared to be independent of, persistent host cell toxicity.
Similar articles
-
A study of the antiviral mechanism of action of 2-deoxy-D-glucose: normally glycosylated proteins are not strictly required for herpes simplex virus attachment but increase viral penetration and infectivity.Virology. 1982 Nov;123(1):123-38. doi: 10.1016/0042-6822(82)90300-2. Virology. 1982. PMID: 6293188 No abstract available.
-
In vitro effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5'-amino-5-iodo-2',5'-dideoxyuridine and 2-deoxy-D-glucose on latent ganglionic herpes simplex virus infection.Antiviral Res. 1984 Apr;4(1-2):53-61. doi: 10.1016/0166-3542(84)90025-1. Antiviral Res. 1984. PMID: 6331305
-
Unusual membranous structures found in cells infected with herpes simplex virus type 2 maintained in media containing 2-deoxy-D-glucose.Microbiol Immunol. 1978;22(9):575-9. doi: 10.1111/j.1348-0421.1978.tb00406.x. Microbiol Immunol. 1978. PMID: 215884 No abstract available.
-
Inhibition of the multiplication of enveloped viruses by glucose derivatives.Curr Top Microbiol Immunol. 1975;70:101-19. doi: 10.1007/978-3-642-66101-3_4. Curr Top Microbiol Immunol. 1975. PMID: 808397 Review. No abstract available.
-
Glucose analogues in the chemotherapy of herpesvirus infections.Pharmacol Ther. 1980;10(3):669-81. doi: 10.1016/0163-7258(80)90033-9. Pharmacol Ther. 1980. PMID: 6255498 Review. No abstract available.
Cited by
-
Expression of herpes simplex virus type 1 (HSV-1) latency-associated transcripts and transcripts affected by the deletion in avirulent mutant HFEM: evidence for a new class of HSV-1 genes.J Virol. 1988 Sep;62(9):3281-7. doi: 10.1128/JVI.62.9.3281-3287.1988. J Virol. 1988. PMID: 2841480 Free PMC article.
-
Carnosic Acid Inhibits Herpes Simplex Virus Replication by Suppressing Cellular ATP Synthesis.Int J Mol Sci. 2024 May 3;25(9):4983. doi: 10.3390/ijms25094983. Int J Mol Sci. 2024. PMID: 38732202 Free PMC article.
-
Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection.J Virol. 1988 May;62(5):1479-85. doi: 10.1128/JVI.62.5.1479-1485.1988. J Virol. 1988. PMID: 2833602 Free PMC article.
-
Novobiocin and coumermycin A1 inhibit viral replication and the reactivation of herpes simplex virus type 1 from the trigeminal ganglia of latently infected mice.J Virol. 1987 Oct;61(10):3288-91. doi: 10.1128/JVI.61.10.3288-3291.1987. J Virol. 1987. PMID: 3041048 Free PMC article.
-
Detection of herpes simplex virus type 1 transcripts during latent infection in mice.J Virol. 1987 Dec;61(12):3841-7. doi: 10.1128/JVI.61.12.3841-3847.1987. J Virol. 1987. PMID: 2824818 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources